Discontinuation report LIORESAL D.S. TAB 20MG
| Report ID | 103075 |
| Drug Identification Number | 00636576 |
| Brand name | LIORESAL D.S. TAB 20MG |
| Common or Proper name | LIORESAL D.S. 20MG CT 100'S |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BACLOFEN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100'S |
| ATC code | M03BX |
| ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-01-31 |
| Actual discontinuation date | 2020-01-31 |
| Remaining supply date | 2020-01-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Lot on remaining supply expires June 30, 2020 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-01-10 | English | Compare |
| v2 | 2020-01-10 | French | Compare |
| v3 | 2020-02-24 | English | Compare |
| v4 | 2020-02-24 | French | Compare |
Showing 1 to 4 of 4